Osteoporosis Health Center
This article is from the WebMD News Archive
Calcium Supplements Thwart Bone Loss
Aug. 23, 2007 -- Confused about whether calcium supplements and vitamin D supplements protect your bones?
A report in this week's edition of The Lancet sheds new light on that question.
People aged 50 and older who take calcium supplements are 12% less likely to fracture a bone than their peers who don't take those pills.
That protection rate doubles when calcium supplements are taken correctly, report the researchers, who included Benjamin Tang, MD, of the Centre for Complementary Medicine Research at Australia's University of Western Sydney.
"For best therapeutic effect, we recommend minimum doses of 1200 milligrams [mg] of calcium, and 800 IU [international units] of vitamin D (for combined calcium plus vitamin D supplementation)," Tang's team writes.
Tang and colleagues reviewed 29 studies on the use of calcium supplements and vitamin D supplements in people aged 50 and older. Together, the studies included nearly 64,000 people who were almost 68 years old, on average.
Participants were followed for 3.5 years, on average.
During that time, people who took calcium supplements were not only less likely to fracture their bones, they also slightly reduced their rate of bone loss from their hip and spine, compared with people who didn't take calcium supplements.
Taking vitamin D supplements along with calcium supplements didn't budge the numbers much. But that may be because few studies used higher doses of vitamin D, according to the report.
People aged 70 and older, those who didn't get much calcium from their diets, thin people, and those at high risk of bone fractures were particularly likely to benefit from taking calcium supplements.
Weight-bearing exercise, which helps strengthen bones, wasn't covered in the study.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


